Important Information
This website is managed by Ultima Markets’ international entities, and it’s important to emphasise that they are not subject to regulation by the FCA in the UK. Therefore, you must understand that you will not have the FCA’s protection when investing through this website – for example:
Note: Ultima Markets is currently developing a dedicated website for UK clients and expects to onboard UK clients under FCA regulations in 2026.
If you would like to proceed and visit this website, you acknowledge and confirm the following:
Ultima Markets wants to make it clear that we are duly licensed and authorised to offer the services and financial derivative products listed on our website. Individuals accessing this website and registering a trading account do so entirely of their own volition and without prior solicitation.
By confirming your decision to proceed with entering the website, you hereby affirm that this decision was solely initiated by you, and no solicitation has been made by any Ultima Markets entity.
I confirm my intention to proceed and enter this websiteOn Monday, the Hang Seng Index rose 218 points or 1.25% to close at 17,636, partially recovering from the previous session’s 2.0% decline. The upturn came after the People’s Bank of China (PBoC) unexpectedly cut its key short-term policy rate for the first time in nearly a year, aiming to stimulate economic growth in China. The PBoC also reduced loan prime rates to new lows, following disappointing Q2 GDP figures and the conclusion of the Third Plenum meeting.
The market rebounded from a near 3-month low, with the tech sector surging 2.1% on beliefs that Beijing’s policies would benefit the industry long-term. Financials and consumer stocks also gained ground.
However, the market’s rise was tempered by concerns that China’s rate cuts might indicate Beijing’s acknowledgment of economic difficulties. Among big-cap stocks, Pharmaron led the gains, jumping 6.0% after forecasting a 34-45% year-on-year increase in H1 net profit. Other top performers included Trip.Com (4.7%), Xiaomi Corp. (4.1%), and Innovent Biologics (3.8%).
(Hang Seng Index Six-month Chart)
Disclaimer
Comments, news, research, analysis, price, and all information contained in the article only serve as general information for readers and do not suggest any advice. Ultima Markets has taken reasonable measures to provide up-to-date information, but cannot guarantee accuracy, and may modify without notice. Ultima Markets will not be responsible for any loss incurred due to the application of the information provided.
Ultima Markets provides the foremost competitive cost and exchange environment for prevalent commodities worldwide.
Start TradingMonitoring the market on the go
Markets are susceptible to changes in supply and demand
Attractive to investors only interested in price speculation
Deep and diverse liquidity with no hidden fees
No dealing desk and no requotes
Fast execution via Equinix NY4 server